Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial (Q38393636)
Jump to navigation
Jump to search
scientific article published on 14 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial |
scientific article published on 14 April 2016 |
Statements
1 reference
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial (English)
1 reference
Ahmad Awada
Igor Bondarenko
Rajendra A Badwe
Georgia Demetriou
Soo-Chin Lee
Ajay O Mehta
Sung-Bae Kim
Chanchal Goswami
Suryanarayan Deo
Ron Bose
Alvin Wong
Feng Xu
Bin Yao
Richard Bryce
14 April 2016
1 reference